Dialysis kinetics of homocysteine and reactive oxygen species

ASAIO Journal

Volumn 44, Issue 5, 1998, Pages

  Biasioli, Stefano ^a   Schiavon, Renzo ^a   Petrosino, Luigi ^a   Cavallini, Lucia ^a   Cavalcanti, Gaetano ^a   De Fanti, Emanuela ^a  

^a Legnago General Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; ENZYMES; FILTRATION; LIPIDS; PATIENT TREATMENT;

HEMODIALYSIS; HOMOCYSTEINE; OXIDATIVE STRESS;

DIALYSIS;

CYSTEINE; FLAVINE ADENINE NUCLEOTIDE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; HOMOCYSTEINE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BIOFILTRATION; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MALE; MEMBRANE BINDING; OXIDATIVE STRESS;

EID: 0032170410     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199809000-00020     Document Type: Article

References (61)

1. Rosemund A, Binswanger U, Straub W: Oxidative injury to erythrocytes, cell rigidity and splenic haemolysis in haemodialyzed uremic patients. Ann Intern Med 82: 460-465, 1975.
2. Kikuchi Y, Koyama T, Koyama Y, et al: Red blood cell deformability in renal failure. Nephron 30: 8-14, 1982.
3. Lindsay RM, Moorthy AV, Koens F, Linton AL: Platelet function in dialyzed patients with chronic renal failure. Clin Nephrol 4: 52-57, 1975.
4. Gutteridge J: Lipid peroxidation and antioxidant as biomarkers of tissue damage. Clin Chem 41: 1819-1828, 1995.
5. Kuroda M, Asaka S, Tofuku Y, Takeda R: Serum antioxidant activity in uraemic patients. Nephron 41: 293-298, 1986.
6. Ono K: Effects of large dose vitamin E supplementation on anaemia in haemodialysis patients. Nephron 40: 440-445, 1985.
7. Taccone-Gallucci M, Giardini O, Lubrano R, et al: Red blood cell peroxidation in pre-dialysis renal failure. Clin Nephrol 27: 238-241, 1987.
8. Taccone-Gallucci M, Lubrano R, Bandino D, et al: Discrepancies between serum and erythrocyte concentrations of vitamin E in haemodialysis patients: role of HDL-bound fraction of vitamin E. Artif Organs 12: 379-381, 1988.
9. Yawata Y, Jacob H: Abnormal red cell metabolism in patients with chronic anemia: nature of the defect and its persistence despite adequate haemodialysis. Blood 45: 231-239, 1975.
10. Himmelfarb J, Lazarus M, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 3: 271-276, 1991.
11. Luciak M, Trznadel K: Free oxygen species metabolism during haemodialysis with different membranes. Nephrol Dial Transplant Suppl 3: 66-70, 1991.
12. Miguel A, Linares M, Perez A, et al: Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Nephron 50: 64-65, 1988.
13. Richard MI, Arnaud J, Iurkovilz C, et al: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57: 10-15, 1991.
14. Fillit H, Elion E, Sullivan J, Sherman R, Zabriskie IB: Thiobarbituric acid reactive material in uraemic blood. Nephron 29: 40-43, 1981.
15. Dasgupta A, Hussain S, Ahmad S: Increased lipid peroxidation in patients on maintenance haemodialysis. Nephron 60: 56-59, 1992.
16. Taylor IE, Scou N, Bridges A, Henderson IS, Stewart WK, Belch JJF: Lipid peroxidation in continuous ambulatory dialysis patients. Perit Dial Inf 12: 252-256, 1992.
17. Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E: Effect of haemodialysis in lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 41: 1229-1232, 1992.
18. Giardini O, Taccone-Gallucci M, Lubrano R, et al: Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron 36: 235-237, 1984.
19. Maher ER Wickens DG, Griffin IFA, Kyle P, Curtis JR, Dormandy TL: Neutropenia and plasma free radical reaction products during haemodialysis. Nephrol Dial Transplant 3: 277-283, 1988.
20. McGrath LT, Douglas AF, McClean E, et al: Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular HD. Clin Chim Acta 235: 179-188, 1995.
21. Girelli D, Azzini M, Olivieri O, et al: Red blood cells and platelet membrane fatty acids in nondialyzed and dialyzed uremics Clin Chim Acta 211: 155-166, 1992.
22. Chauhan DP, Gupta PH, Nampoothiri MRN, Singhal PC, Chugh KS, Nair CR: Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uraemia. Clin Chim Acta 123: 153-159, 1982.
23. Tzrnadel K, Pawlicki L, Kedziora J, Luciak M, Blaszozyk J, Buczynski A: Superoxide anion generation, erythrocytes superoxide dismutase activity and lipid peroxidation during haemoperfusion and haemodialysis in chronic uremie patients. Free Radic Biol Med 6: 393-397, 1989.
24. Delmas-Beauviex MC, Combe C, Penchant E, Carboneau MA: Evaluation of RCB lipoperoxidation in HD patients during EPO therapy supplemented or not with iron. Nephron 69: 404-410, 1995.
25. Taccone-Gallucci M, Lubrano R, Del Principe D, et al: Platelet lipid peroxidation in haemodialysis patients: effects of vitamin E supplementation. Nephrol Dial Transplant 4: 975-978, 1989.
26. Vanella A, Geromia E, Pinturo R: Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis. Acta Haematol 70: 312-315, 1983.
27. Giardini O, Taccone-Gallucci M, Lubrano R: Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in haemodialysis patients. Clin Nephrol 21: 174-177, 1984.
28. Cornelis R, Mees L, Ringoir S: Serum and red blood cell Zn, Se, Cs and Rb in dialysis patients. Miner Electrolyte Metab 2: 85-93, 1979.
29. Biasioli S, Schiavon R, De Fanti E, Cavalcanti G, Giavarina D: The role of erythrocytes in the deperoxidative processes in people on HD. ASAIO J 42: 890-894, 1996.
30. Biasioli S, Schiavon R, Petrosino L, et al: Free radicals and oxidative stress challenge dialysis patients: effects of two different membranes. ASAIO J 43: M766-772, 1997.
31. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 338: 1042-1049, 1998.
32. Malinow MR, Duell PB, Hess DL, et al: Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 338: 1009-1015, 1998.
33. Gunzler WA, Kremers H, Flohe L: An improved coupled test procedure for glutathione peroxidase in blood. Zeitschrift fur Klinische Chemie und Klinische Biochemie 12: 444-448, 1974.
34. Beutler E: Red Cell Metabolism: A Manual of Biochemical Methods. 2nd ed. New York, Grune and Stratton, 1975, pp. 71-73.
35. Smilh CV, Anderson RE: Methods for determination of lipid peroxidation in biological samples. Free Radic Biol Med 3: 341-344, 1987.
36. Vester B, Rasmussen K: HPLC method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 29: 549-554, 1991.
37. Westhuyzen J, Adams CE, Fleming SJ: Evidence for oxidative during in vitro dialysis. Nephron 70: 49-54, 1995.
38. Sanaka T, Higuchi C, Shinobe T, Nishimura H, Omata M: Lipid peroxidation as an indicator of biocompatibility in H D. Nephrol Dial Transplant 10: 34-38, 1995.
39. Paul JP, Sall N, Soni T, et al: Lipid peroxidation abnormalities in HD patients. Nephron 64: 106-109, 1993.
40. Durak J, Akyiol O, Basesme E, Canbolat O, Kavutcu M: Reduced erythrocyte defense mechanism against free radical toxicity in patients with CRF. Nephron 66: 76-80, 1994.
41. Turi S, Nemeth I, Varga I, Matcoviks B, Dobos E: Erythrocyte defense mechanism against free oxygen radicals in HD children. Pediatr Nephrol 5: 179-83, 1991.
42. Seth RK, Satni AS, Aggarwal SK: Glutathione peroxidase and reduced glutathione content in erythrocytes of patients with CRF. Scand J Haematol 35: 201-4, 1985.
43. Asayama K, Shiki Y, Ito H, Hasegawa O, Miyao A: Antioxidant enzymes and liperoxide in blood in uremic children and adolescent. Free Radic Biol Med 9: 105-9, 1990.
44. Melissinos KG, Delidou AZ, Varsou AG, Begietti SS, Drivas GJ: Serum and erythrocyte glutathione reductase activity in chronic renal failure. Nephron 28: 76-79, 1981.
45. Mimic-Oka J, Djukanovic LJ, Markovic B: Erythrocyte and plasma glutathione levels in patients with chronic renal insufficiency. Biochem Med Metab Biol 39: 48-54, 1988.
46. Mimic-Oka J, Simic T, Djukanovic LJ, Stefanovski J, Ramic Z: Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency. Amino Acids 2: 215-224, 1992.
47. Mimic-Oka J, Simic T, Ekmescic V, Dragicevic P: Erythrocyte GP and SOD activities in different stages of CRF. Clin Nephrol 44: 44-45, 1995.
48. Jackson P, Loughrey CM, Lightbody J, McNamec P, Young L: Effects of HD on total antioxidant capacity and serum antioxidants in patients with CRF. Clin Chem 41: 1-135-1138, 1995.
49. Amstad P, Moret R, Cerutti P: Glutathione peroxidase compensates for the hypersensitivity of cuprophan, Zn superoxide dismutase over producers to oxidant stress. J Biol Chem 269: 1606-1609, 1994.
50. Sheriff DS: Erythrocyte glutathione concentration as a measure of oxidant stress in patients undergoing dapsone therapy. Ann Clin Biochem 26: 199-200, 1989.
51. Pascucci M, Canestrari F, Galli F, Biagiarelli B, Galiotta P: Stress eritrocitario nei trattamenti dialitici extracorporei: livelli enzimatici, stato energetico e redox. Giornale Italiano di Nefrologia 9: 183-88, 1992.
52. Hashimoto H, Mio T, Sumino K: Lipid abnormalities of erythrocyte membranes in HD patients with CRF. Clin Chim Acta 252: 137-145, 1996.
53. Witko SV, Friedlander M, Capeillere C, Nguyen K, Zingraff J: Advanced oxidation protein product as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996.
54. Odetti P, Garibaldi S, Gurreri G, Aragno I, Dapino D: Protein oxidation in HD and kidney transplantation. Metabolism 45: 1319-1322, 1996.
55. Lin T, Chen JG, Liaw JM, Juang JG: Trace elements and lipid peroxidation in uremic patients on HD. Biol Trace Elem Res 51: 277-283, 1996.
56. Banni S, Lucchi L, Baraldi A, et al: No direct evidence of increased lipid peroxidation in HD patients. Nephron 7: 177-183, 1996.
57. Nagase S, Aoyagi K, Hirayama A, Gotoh M: Decreased serum antioxidant activity of HD patients demonstrated by methylguanidine synthesis and microsomal lipid peroxidation. Nephron 74: 1555-560, 1996.
58. Eisselt J, Racek J, Holecek V, Krejcova I: Antioxidant and malondialdehyde during HD with CDA and PS membranes. Cas Lek Cesk 135: 691-694, 1996.
59. Loscalzo J: The oxidant stress of hyperhomocysteinemia. J Clin Invest 98: 5-7, 1996.
60. Welch GN, Upchurch GR Jr, Loscalzo J: Hyperhomocysteinemia and atherothrombosis. Ann N Y Acad Sci 811: 48-58, 1997.
61. Chauveau P, Chadefaux B, Coüde M et al: Hyperhomocysteinemia, a risk factor for atherosclerosis of chronic uremic patients. Kidney Int 41: 572-577, 1993.